ESC Premium Access

The HAS-BLED score for prediction of stroke and systemic embolism: insights from the PREvention oF thromboembolic events, European Registry in Atrial Fibrillation (PREFER in AF)

Congress Session

About the speaker

Doctor Miklos Rohla

Wilhelminen Hospital, 3rd Department of Internal Medicine, Cardiology and Emergency Medicine, Vienna (Austria)
0 follower

20 more presentations in this session

Prothrombin activation fragment (F1+2) as an index of anticoagulant therapy with factor Xa inhibitor in atrial fibrillation

Speaker: Doctor E. Ueno (Kahoku, JP)

Thumbnail

Is there a difference in treatment persistence across oral anticoagulants? Results of a UK cohort study evaluating oral anticoagulation therapy in an atrial fibrillation population

Speaker: Ms G. Stynes (Uxbridge, GB)

Thumbnail

Is major bleeding risk for oral anticoagulants similar between non-valvular atrial fibrillation patients newly initiated on warfarin and propensity-score matched NOAC initiators? A real world study

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Differences in the characteristics of patients with non-valvular atrial fibrillation who are newly prescribed apixaban, rivaroxaban, dabigatran and VKA in general practice in the UK

Speaker: Ms G. Stynes (Uxbridge, GB)

Thumbnail

Anticoagulation management in patients with atrial fibrillation undergoing elective electrical cardioversion

Speaker: Doctor O. Erkuner (Maastricht, NL)

Thumbnail

Access the full session

Poster session 3 - Anticoagulation in atrial fibrillation

Speakers: Doctor M. Rohla, Doctor E. Ueno, Ms G. Stynes, Professor G. Lip, Ms G. Stynes...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk